`
`
`
`
`
`
`
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`BRECKENRIDGE PHARMACEUTICAL, INC. and WEST-WARD
`PHARMACEUTICALS INTERNATIONAL LIMITED
`Petitioners
`
`v.
`
`NOVARTIS AG
`Patent Owner
`
`Case IPR2017-01592
`U.S. Patent No. 8,410,131
`
`
`
`
`
`Before SHERIDAN K. SNEDDEN, ROBERT A. POLLACK, and
`JACQUELINE T. HARLOW, Administrative Patent Judges.
`
`
`
`
`WEST-WARD PHARMACEUTICALS INTERNATIONAL LIMITED’S
`REQUEST FOR ORAL ARGUMENT
`
`
`
`Case IPR2017-01592
`U.S. Patent No. 8,410,131
`
`
`
`Pursuant to 37 C.F.R. § 42.70, and the Board’s Scheduling Order dated
`
`January 3, 2018 (Paper 13), Petitioner West-Ward Pharmaceuticals International
`
`Limited (“Petitioner”) respectfully requests oral argument on issues related to the
`
`patentability of claims 1-3 and 5-9 of U.S. Patent No. 8,410,131 (“’131 patent”) on
`
`the instituted grounds set forth in the Board’s Decision (Paper 12) and on any
`
`issues specified in any motions to exclude, motions for observation regarding
`
`cross-examination of reply witnesses, or any other pending motions filed by the
`
`parties. The Board has previously scheduled the oral argument for September 19,
`
`2018. (Paper 13)
`
`Petitioner respectfully request that the Board allow Petitioner and Patent
`
`Owner 45 minutes each to present their arguments, including any time reserved for
`
`rebuttal arguments.
`
`Petitioner respectfully requests that the hearing be held in Room A, in order
`
`to accommodate the law firm representing the Petitioner, the law firm representing
`
`Patent Owner, as well as client representatives who may wish to attend. Petitioner
`
`requests permission to use a computer, projector, and screen to display
`
`demonstratives and exhibits. Petitioner also requests that the attorneys at
`
`
`
`
`
`1
`
`
`
`Case IPR2017-01592
`U.S. Patent No. 8,410,131
`
`
`Petitioner’s counsel table be allowed to use computers.
`
`
`
`
`Dated: August 8, 2018
`
`
`
`
`
`Respectfully submitted,
`
`/Marta E. Delsignore/
`
`By:
`
`Marta E. Delsignore (Reg. No. 32,689)
`GOODWIN PROCTER LLP
`The New York Times Building
`620 Eighth Avenue
`New York, NY 10018-1405
`Tel: 212-813-8822
`Fax: 646-558-4079
`mdelsignore@goodwinprocter.com
`
`Counsel for Petitioner West-Ward
`Pharmaceuticals International Limited
`
`
`
`2
`
`
`
`Case IPR2017-01592
`U.S. Patent No. 8,410,131
`
`
`
`CERTIFICATE OF SERVICE
`
`
`
`I certify that a copy of the foregoing WEST-WARD
`
`PHARMACEUTICALS INTERNATIONAL LIMITED’S REQUEST FOR ORAL
`
`ARGUMENT was served on August 8, 2018 by electronic mail on Patent Owner’s
`
`lead and backup counsel at the following email addresses:
`
`
`
`
`
`
`
`
`Nicholas N. Kallas
`Laura K. Fishwick
`Fitzpatrick, Cella, Harper & Scinto
`nkallas@fchs.com
`lfishwick@fchs.com
`ZortressAfinitorIPR@fchs.com
`
`
`and on Counsel for Petitioner Breckenridge Pharmaceutical, Inc. at the following
`
`email addresses:
`
`
`Daniel R. Evans
`Melissa M. Hayworth
`Jeffrey D. Blake
`Merchant & Gould P.C.
`devans@merchantgould.com
`mhayworth@merchantgould.com
`jblake@merchantgould.com
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`/Marta E. Delsignore/
`
`By:
`
`Marta E. Delsignore (Reg. No. 32,689)
`GOODWIN PROCTER LLP
`The New York Times Building
`620 Eighth Avenue
`New York, NY 10018-1405
`Tel: 212-813-8822
`Fax: 646-558-4079
`mdelsignore@goodwinprocter.com
`
`Counsel for Petitioner West-Ward
`Pharmaceuticals International Limited
`
`Case IPR2017-01592
`U.S. Patent No. 8,410,131
`
`
`Dated: August 8, 2018
`
`
`
`
`
`